Integration of Care in the Implementation of the Affordable Care Act: Changes in Treatment Services in a National Sample of Centers Treating Substance Use Disorders

Journal of Psychoactive Drugs

Volumn 49, Issue 2, 2017, Pages 132-140

  Aletraris, Lydia ^a   Roman, Paul M ^a   Pruett, Jana ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Affordable Care Act; medical staffing; medication assisted treatment; SBIRT; substance use disorder treatment

Indexed keywords

ACAMPROSATE; ALCOHOL; ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUPRENORPHINE; CLOZAPINE; DIAZEPAM; DISULFIRAM; FLUOXETINE; LITHIUM; METHADONE; MONOAMINE OXIDASE INHIBITOR; NALTREXONE; NEUROLEPTIC AGENT; OPIATE; PAROXETINE; RISPERIDONE; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; NARCOTIC ANTAGONIST;

ALCOHOLISM; ARTICLE; DETOXIFICATION; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; EXPECTATION; FUNDING; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH ECONOMICS; HEPATITIS C; HUMAN; INTEGRATED HEALTH CARE SYSTEM; LIKERT SCALE; MAJOR CLINICAL STUDY; MEDICAL CARE; MEDICAL STAFF; MEDICALIZATION; MEDICARE; MENTAL DISEASE; PATIENT CARE; PATIENT REFERRAL; PHILOSOPHY; PHYSICIAN; PRIMARY MEDICAL CARE; PRIVATE HEALTH INSURANCE; PSYCHOPHARMACOTHERAPY; ORGANIZATION AND MANAGEMENT; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; TRENDS; UNITED STATES;

DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; MEDICALIZATION; NALTREXONE; NARCOTIC ANTAGONISTS; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PHYSICIANS; REFERRAL AND CONSULTATION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 85016098377     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2017.1299263     Document Type: Article

References (37)

1. Aletraris, L., M. B., Edmond, M., Paino, D., Fields, and P. M., Roman. 2016. Counselor training and attitudes toward pharmacotherapies for opioid use disorder. Substance Abuse 37 (1):47–53. doi:10.1080/08897077.2015.1062457.
2. Aletraris, L., M. B., Edmond, and P. M., Roman. 2015. Adoption of injectable naltrexone in U.S. substance use disorder treatment programs. Journal of Studies on Alcohol and Drugs 76 (1):143–51. doi:10.15288/jsad.2015.76.143.
3. Aletraris, L., and P. M., Roman. 2015. Provision of onsite HIV services in substance use disorder treatment programs:A longitudinal analysis. Journal of Substance Abuse Treatment 57:1–8. doi:10.1016/j.jsat.2015.04.005.
4. Aletraris, L., J. S., Shelton, and P. M., Roman. 2015. Counselor attitudes toward contingency management for substance use disorder:Effectiveness, acceptability and endorsement of incentives for treatment attendance and abstinence. Journal of Substance Abuse Treatment 57:41–48. doi:10.1016/j.jsat.2015.04.012.
5. Babor, T. F., B. G., McRee, P. A., Kassebaum, P. L., Grimaldi, K., Ahmed, and J., Bray. 2007. Screening, Brief Intervention, and Referral to Treatment (SBIRT):Toward a public health approach to the management of substance abuse. Substance Abuse 28 (3):7–10. doi:10.1300/J465v28n03_03.
6. Barry, C. L., and H. A., Huskamp. 2011. Moving beyond parity—mental health and addiction care under the ACA. New England Journal of Medicine 365 (11):973–75. doi:10.1056/NEJMp1108649.
7. Bride, B. E., Y. J., Choi, I. W., Olin, and P. M., Roman. 2016. Patient violence towards counselors in substance use disorder treatment programs:Prevalence, predictors, and responses. Journal of Substance Abuse Treatment 57:9–17. doi:10.1016/j.jsat.2015.04.004.
8. Buck, J. A., 2011. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Affairs 30 (8):1402–10. doi:10.1377/hlthaff.2011.0480.
9. Edmond, M. B., L., Aletraris, M., Paino, and P. M., Roman. 2015. Treatment strategy profiles in substance use disorder treatment programs:A latent class analysis. Drug and Alcohol Dependence 153:109–15. doi:10.1016/j.drugalcdep.2015.05.047.
10. Friedmann, P. D., D., McCollough, M. H., Chin, and R., Saitz. 2000. Screening and intervention for alcohol problems:A national survey of primary care physicians and psychiatrists. Journal of General Internal Medicine 15 (2):84–91. doi:10.1046/j.1525-1497.2000.03379.x.
11. Garfield, R. L., S. H., Zuvekas, J. R., Lave, and J. M., Donohue. 2011. The impact of national health care reform on adults with severe mental disorders. American Journal of Psychiatry 168 (5):486–94. doi:10.1176/appi.ajp.2010.10060792.
12. Henry J. Kaiser Foundation. 2014. Health reform implementation timeline. http://kff.org/interactive/implementation-timeline/ (accessed December 1, 2016).
13. Henry J. Kaiser Foundation. 2016. The Affordable Care Act after six years. http://kff.org/health-reform/perspective/the-affordable-care-act-after-six-years/ (accessed December 1), 2016.
14. Hutchinson, E., M., Catlin, C., Andrilla, L., Baldwin, and R., Rosenblatt. 2014. Barriers to primary care physicians prescribing buprenorphine. The Annals of Family Medicine 12 (2):128–33. doi:10.1370/afm.1595.
15. Knudsen, H. K., 2015. The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States:A state-level analysis. Journal of Studies on Alcohol and Drugs 76 (4):644–54. doi:10.15288/jsad.2015.76.644.
16. Knudsen, H. K., A. J., Abraham, and C. B., Oser. 2011. Barriers to the implementation of medication-assisted treatment for substance use disorders:The importance of funding policies and medical infrastructure. Evaluation and Program Planning 34:375–81. doi:10.1016/j.evalprogplan.2011.02.004.
17. Knudsen, H. K., and P. M., Roman. 2016. The diffusion of acamprosate for the treatment of alcohol use disorder:Results from a national longitudinal study. Journal of Substance Abuse Treatment 62:62–67. doi:10.1016/j.jsat.2015.10.005.
18. Knudsen, H. K., P. M., Roman, and C., Oser. 2010. Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations. Journal of Addiction Medicine 4:99–107. doi:10.1097/ADM.0b013e3181b41a32.
19. Madras, B. K., W. M., Compton, D., Avula, T., Stegbaur, J. B., Stein, and H. W., Clark. 2009. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites:Comparison at intake and 6 months later. Drug and Alcohol Dependence 99 (1–3):280–95. doi:10.1016/j.drugalcdep.2008.08.003.
20. Mark, T. L., K. R., Levit, R., Vandivort-Warren, J. A., Buck, and R. M., Coffey. 2011. Changes in US spending on mental health and substance abuse treatment, 1986–2005, and implications for policy. Health Affairs 30:284–92. doi:10.1377/hlthaff.2010.0765.
21. Mark, T. L., L. M., Wier, K., Malone, M., Penne, and A. J., Cowell. 2015. National estimates of behavioral health conditions and their treatment among adults newly insured under the ACA. Psychiatric Services 66:426–29. doi:10.1176/appi.ps.201400078.
22. McCarty, D., D., Gustafson, V. A., Capoccia, and F., Cotter. 2009. Improving care for the treatment of alcohol and drug disorders. Journal of Behavioral Health Services & Research 36:52–60. doi:10.1007/s11414-008-9108-4.
23. Mee-Lee, D. L., L., Gartner, M. M., Miller, G. D., Shulman, and B. B., Wilford. 1996. Patient placement criteria for the treatment of substance related disorders, 2nd ed. Chevy Chase, MD:American Society of Addiction Medicine.
24. Polydorou, S., E. W., Gunderson, and F. R., Levin. 2008. Training physicians to treat substance use disorders. Current Psychiatry Reports 10:399–404. doi:10.1007/s11920-008-0064-8.
25. Rahm, A. K., Boggs, J. M., Martin, C. M., Price, D. W., Beck, A., Backer, T. E., and Dearing, J. W. 2015. Facilitators and barriers to implementing SBIRT in primary care in integrated health care settings. Substance Abuse 36 (3):281-88.
26. Rogers, E. M., 2003. Diffusion of innovations, 5th ed. New York, NY:The Free Press.
27. Roman, P. M., A. J., Abraham, and H. K., Knudsen. 2011. Using medication-assisted treatment for substance use disorders:Evidence of barriers and facilitators of implementation. Addictive Behaviors 36:584–89. doi:10.1016/j.addbeh.2011.01.032.
28. Samet, J. H., P., Friedmann, and R., Saitz. 2001. Benefits of linking primary medical care and substance abuse services:Patient, provider, and society perspectives. Archives of Internal Medicine 161 (1):85–91. doi:10.1001/archinte.161.1.85.
29. Saxon, A. J., and D., McCarty. 2005. Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs. Pharmacology and Therapeutics 108:119–28. doi:10.1016/j.pharmthera.2005.06.014.
30. Substance Abuse and Mental Health Services Administration. 2011. Evidence supporting the effectiveness of an SBIRT. http://www.samhsa.gov/sites/default/files/sbirtwhitepaper_0.pdf
31. Tai, B., and N. D., Volkow. 2013. Treatment for substance use disorder:Opportunities and challenges under the Affordable Care Act. Social Work in Public Health 28:165–74. doi:10.1080/19371918.2013.758975.
32. Terry-McElrath, Y. M., J. F., Chriqui, and D. C., McBride. 2011. Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs. Health Services Research 46:632–53. doi:10.1111/hesr.2011.46.issue-2.
33. Thomas, C. P., S. S., Wallack, S., Lee, D., McCarty, and R., Swift. 2003. Research to practice:Adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment 24:1–11. doi:10.1016/S0740-5472(02)00319-7.
34. Urada, D., C., Teruya, L., Gelberg, and R., Rawson. 2014. Integration of substance use disorder services with primary care:Health center surveys and qualitative interviews. Substance Abuse Treatment, Prevention, and Policy 9:15. doi:10.1186/1747-597X-9-15.
35. Weisner, C., J., Mertens, A., Parthasarathy, C., Moore, and Y., Lu. 2001. Integrating primary medical care with addiction treatment:A randomized controlled trial. Journal of the American Medical Association 286 (14):1715–23. doi:10.1001/jama.286.14.1715.
36. Woodward, A., 2015. The CBHSQ report:The substance abuse prevention and treatment block grant is still important even with the expansion of Medicaid. Rockville, MD:Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality.
37. World Health Organization. 2008. The effectiveness of a brief intervention for illicit drugs linked to the Alcohol, Smoking, and Substance Involvement Screening test (ASSIST) in primary health care settings:A technical report of phase III findings of the WHO ASSIST randomized control trial. http://www.who.int/substance_abuse/activities/assist_technicalreport_phase3_final.pdf